Slomovitz BM, Cibula D, Lv W, Ortac F, et al. Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors. J Clin Oncol 2025;43:251-259.
PMID: 39411812